Al-Naimi Marwa S, Rasheed Huda A, Hussien Nawar R, Al-Kuraishy Hayder M, Al-Gareeb Ali I
Department of Clinical Pharmacology, College of Pharmacy, Al-Mustansiriya University, Baghdad, Iraq.
Department of Clinical Pharmacology, Medicine and Therapeutic, Medical Faculty, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq.
J Adv Pharm Technol Res. 2019 Jul-Sep;10(3):95-99. doi: 10.4103/japtr.JAPTR_336_18.
Nephrotoxicity is defining as rapid deterioration in the kidney function due to toxic effect of medications and chemicals. There are various forms, and some drugs may affect renal function in more than one way. Nephrotoxins are substances displaying nephrotoxicity. Different mechanisms lead to nephrotoxicity, including renal tubular toxicity, inflammation, glomerular damage, crystal nephropathy, and thrombotic microangiopathy. The traditional markers of nephrotoxicity and renal dysfunction are blood urea and serum creatinine which are regarded as low sensitive in the detection of early renal damage. Thus, the detection of the initial renal injures required new biomarkers which are more sensitive and highly specific that gives an insight into the site of underlying renal damage. Kidney injury molecule-1, Cystatin C, and neutrophil gelatinase-associated lipocalin sera levels are more sensitive than blood urea and serum creatinine in the detection of acute kidney injury during nephrotoxicity.
肾毒性被定义为由于药物和化学物质的毒性作用导致肾功能迅速恶化。肾毒性有多种形式,一些药物可能通过不止一种方式影响肾功能。肾毒素是表现出肾毒性的物质。不同的机制导致肾毒性,包括肾小管毒性、炎症、肾小球损伤、结晶性肾病和血栓性微血管病。肾毒性和肾功能障碍的传统标志物是血尿素和血清肌酐,它们在早期肾损伤检测中被认为敏感性较低。因此,检测初始肾损伤需要更敏感、高度特异的新型生物标志物,以便深入了解潜在肾损伤的部位。在肾毒性期间检测急性肾损伤时,肾损伤分子-1、胱抑素C和中性粒细胞明胶酶相关脂质运载蛋白的血清水平比血尿素和血清肌酐更敏感。